Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

12 Health Care Stocks Moving In Tuesday's After-Market Session

Author: Benzinga Insights | February 20, 2024 05:31pm

Gainers

  • Motus GI Hldgs (NASDAQ:MOTS) shares rose 53.3% to $1.0 during Tuesday's after-market session. The company's market cap stands at $1.5 million.
  • Acutus Medical (NASDAQ:AFIB) shares increased by 39.45% to $0.33. The company's market cap stands at $9.8 million.
  • Clearside Biomedical (NASDAQ:CLSD) shares rose 12.39% to $1.45. The market value of their outstanding shares is at $108.3 million.
  • NeoGenomics (NASDAQ:NEO) stock increased by 11.42% to $16.38. The market value of their outstanding shares is at $2.0 billion. The company's, Q4 earnings came out today.
  • Universe Pharmaceuticals (NASDAQ:UPC) stock moved upwards by 9.09% to $1.92. The company's market cap stands at $7.0 million.
  • Apyx Medical (NASDAQ:APYX) stock moved upwards by 8.37% to $2.34. The company's market cap stands at $81.1 million.

Losers

  • Community Health Sys (NYSE:CYH) shares decreased by 14.9% to $3.44 during Tuesday's after-market session. The company's market cap stands at $470.5 million. As per the news, the Q4 earnings report came out today.
  • Avinger (NASDAQ:AVGR) shares fell 13.86% to $4.6. The company's market cap stands at $5.8 million.
  • Teladoc Health (NYSE:TDOC) shares declined by 13.23% to $17.78. The company's market cap stands at $2.9 billion. As per the news, the Q4 earnings report came out today.
  • Biofrontera (NASDAQ:BFRI) stock fell 11.31% to $1.02. The company's market cap stands at $1.7 million.
  • Monopar Therapeutics (NASDAQ:MNPR) shares declined by 7.75% to $0.62. The company's market cap stands at $9.1 million.
  • Chemomab Therapeutics (NASDAQ:CMMB) shares decreased by 7.47% to $0.62. The company's market cap stands at $6.9 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: AFIB APYX AVGR BFRI CLSD CMMB CYH MNPR MOTS NEO TDOC UPC

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist